by Clinical trials depend on accurate, consistent, and timely laboratory data. As studies become more global and increasingly involve biomarkers, genomics, biologics, and advanced therapies, central laboratories have become an important part of clinical development.
Unlike individual site laboratories, central labs use standardized testing processes across multiple trial locations. This helps sponsors bring laboratory data together in a consistent format while supporting sample management, testing, analysis, and clinical decision-making.
According to Towards Healthcare, the global clinical trial central lab services sector was valued at USD 4.54 billion in 2025 and is projected to reach USD 10.54 billion by 2034, expanding at a 9.84% CAGR from 2025 to 2034. North America accounted for approximately 45% of the sector in 2024.
Explore the Full Research Scope: https://www.towardshealthcare.com/download-sample/6138
So, who are the leading providers helping pharmaceutical and biotechnology companies manage laboratory requirements for clinical trials?
What Do Central Labs Do in Clinical Trials?
A central laboratory acts as a centralized testing and data hub for clinical studies. Instead of relying on individual testing procedures at every trial site, sponsors can use a central laboratory to standardize testing and sample analysis.
Services can include:
- Clinical chemistry and hematology
- Biomarker testing
- Genomic and molecular testing
- Immunology and immunogenicity testing
- Flow cytometry
- Pathology and histology
- Microbiology and virology
- Sample processing and storage
- Specimen logistics
- Data management and reporting
Towards Healthcare highlights these services as important components of central laboratory support for clinical development.
Leading Central Lab Service Providers
1. Labcorp Drug Development
Labcorp Drug Development, formerly associated with Covance, is one of the major providers in the clinical trial central laboratory landscape.
Towards Healthcare highlights Labcorp’s combination of laboratory and drug-development capabilities, including biomarker science, immunology, genomics, advanced therapies, sample management, and clinical research support.
This integrated approach can be particularly valuable for sponsors looking to connect laboratory testing with broader clinical development activities.
2. IQVIA
IQVIA is another major provider, combining clinical research, laboratory services, data management, analytics, and technology.
Towards Healthcare identifies IQVIA Laboratories among the leading central laboratory service providers and highlights its capabilities in laboratory testing, biomarker analysis, data management, and technology-enabled clinical trial support.
For global studies, the combination of clinical trial expertise and laboratory capabilities can help sponsors manage complex programs across multiple regions.
3. Eurofins Scientific
Eurofins Scientific is another prominent name in the central laboratory services ecosystem.
Towards Healthcare includes Eurofins among the top clinical trial central lab providers, reflecting its capabilities in laboratory testing and specialized clinical research services.
Its broad laboratory infrastructure makes it relevant for sponsors requiring specialized analytical and clinical testing capabilities.
4. ICON Central Laboratories
ICON Central Laboratories is part of ICON’s broader clinical development platform.
Towards Healthcare identifies ICON Central Laboratories among the leading providers of central laboratory services and notes its capabilities in clinical trial testing, sample processing, diagnostics, and integrated study management.
This integrated model can help sponsors coordinate laboratory activities alongside wider clinical trial operations.
5. PPD, Part of Thermo Fisher Scientific
PPD, part of Thermo Fisher Scientific, is another major provider of clinical laboratory and research services.
Towards Healthcare identifies PPD among the leading central lab providers and notes its capabilities in central laboratory services, sample analysis, and clinical research.
Thermo Fisher’s broader life sciences infrastructure also provides access to analytical technologies and laboratory capabilities supporting pharmaceutical and biotechnology development.
6. Medpace
Medpace combines CRO services with central and bioanalytical laboratory capabilities.
Towards Healthcare identifies Medpace Reference Laboratories as a central lab service provider and highlights Medpace’s broader integrated clinical development capabilities.
This can be useful for sponsors seeking a partner that can connect laboratory services with clinical operations.
7. Q² Solutions
Q² Solutions, a joint venture between IQVIA and Quest Diagnostics, is another important participant in the central laboratory ecosystem.
Towards Healthcare lists Q² Solutions among the leading clinical trial central laboratory providers, with capabilities spanning central lab testing, biomarkers, and genomics.
Its focus on specialized laboratory services makes it particularly relevant to studies requiring advanced testing.
Other Important Providers
The competitive landscape includes a much wider group of specialized providers.
Towards Healthcare also identifies:
- Syneos Health
- Charles River Laboratories
- Parexel International
- SGS Life Sciences
- Frontage Laboratories
- Intertek Group
- BioAgilytix Labs
- ACM Global Laboratories
- CMIC Holdings
- WuXi AppTec
- Synexa Life Sciences
- Altasciences
- Veeda Clinical Research
These organizations offer different combinations of central laboratory testing, bioanalysis, biomarker services, sample management, clinical research, and specialized laboratory capabilities.
Why Central Labs Matter for Global Clinical Trials
Modern clinical trials often involve hundreds or thousands of participants across multiple countries. Without standardized laboratory processes, differences in testing methods and reporting can make clinical data harder to compare.
Central laboratories help address this challenge by creating more consistent testing and data workflows.
Towards Healthcare notes that central laboratories help standardize processes and maintain uniform quality across global trial sites.
For sponsors, this can support:
Consistency: Standardized testing procedures across participating sites.
Data quality: Centralized laboratory data can be easier to manage and analyze.
Operational efficiency: Samples, testing, and reporting can be coordinated through a centralized workflow.
Specialized testing: Sponsors can access advanced biomarker, genomic, molecular, and other laboratory capabilities.
Regulatory readiness: Consistent processes and documentation can support clinical development and regulatory requirements.
Advanced Therapies Are Creating New Laboratory Requirements
The rise of biologics, cell therapies, gene therapies, and precision medicine is changing the requirements placed on central laboratories.
Towards Healthcare reports that advanced therapies represented 16.87% of the central lab sector in 2025 and are expected to be the fastest-growing modality, with a 13.22% CAGR during the forecast period.
These studies can require highly specialized laboratory capabilities, including genomic testing, immunological analysis, biomarker testing, flow cytometry, and specialized sample handling.
As advanced therapies become more common, central laboratories will increasingly need to combine traditional clinical testing with sophisticated molecular and cellular analysis.
Oncology Remains a Major Area of Demand
Oncology is another important driver of central laboratory services.
According to Towards Healthcare, oncology accounted for 32.87% of the central lab sector in 2025, making it the largest therapeutic-area segment.
Cancer clinical trials frequently require complex biomarker testing, molecular profiling, pathology, immunohistochemistry, and other specialized analyses.
The growth of targeted therapies and precision oncology is therefore creating additional demand for laboratories capable of handling sophisticated testing requirements.
Phase III Trials Require Significant Laboratory Support
Clinical trial phase also influences laboratory demand.
Towards Healthcare reports that Phase III trials represented 50.32% of the central lab sector in 2025, making them the largest phase segment.
Large Phase III studies typically involve substantial patient populations and extensive testing requirements. Centralized laboratory infrastructure can help sponsors manage the resulting volume of samples and laboratory data more efficiently.
Technology Is Changing Central Laboratory Services
Central laboratory providers are also investing in digital technologies.
Laboratory informatics, automated workflows, data integration, and advanced analytics are becoming increasingly important as clinical trials generate larger volumes of laboratory information.
Towards Healthcare reports that LabConnect launched LabConnector in August 2025, a technology solution designed to standardize diverse laboratory data into a single HL7 format and enable bidirectional data transfer across participating laboratories.
This illustrates a broader shift toward connected laboratory ecosystems rather than isolated testing services.
What Should Sponsors Look for in a Central Lab Partner?
There is no single provider that is best for every clinical trial. The right partner depends on the study’s therapeutic area, geographic footprint, testing requirements, patient population, and development phase.
However, sponsors should consider:
Global Coverage
Can the provider support samples and testing across the countries where the trial is being conducted?
Specialized Testing
Does it have the capabilities required for biomarkers, genomics, immunology, pathology, or advanced therapies?
Sample Logistics
Can it manage collection kits, transportation, processing, storage, and tracking?
Data Integration
Can laboratory data be integrated efficiently with clinical trial systems?
Quality and Compliance
Does the provider have appropriate quality systems and experience supporting regulated clinical research?
Scalability
Can the laboratory accommodate the growing volume and complexity of samples as a study progresses?
Insights from Payal Rabde – bringing a strategic perspective to evolving healthcare trends and developments.
The Future of Central Laboratory Services
Central laboratories are becoming more than testing facilities. They are increasingly becoming data, biomarker, sample-management, and technology hubs within clinical development.
Towards Healthcare estimates that the broader central lab sector will grow from USD 7.17 billion in 2026 to USD 15.78 billion by 2035, representing a 9.16% CAGR.
The strongest providers will likely be those capable of combining:
Advanced testing + sample logistics + biomarker expertise + digital data integration + specialized technologies
This will be particularly important as clinical trials become more decentralized, personalized, biomarker-driven, and focused on advanced therapies.
Get smarter healthcare insights with our dedicated Ecosystem Dashboard
https://www.towardshealthcare.com/access-dashboard
About Us
Pharma Geek is a part of Towards Healthcare Research & Consulting which is a global healthcare market research and consulting firm dedicated to helping businesses make informed decisions through reliable market intelligence and strategic insights. We serve pharmaceutical, biotechnology, medical device, AI in healthcare, cell and gene therapy, digital health, and life sciences organizations with in-depth market research, custom consulting, competitive analysis, and growth forecasts. Our team combines industry expertise with rigorous research to deliver clear, actionable insights that support market expansion, product strategy, investment decisions, and long-term business growth. From emerging innovations to established healthcare markets, we help organizations understand where the industry is today and where it’s headed tomorrow.
You can place an order or ask any questions, please feel free to contact us at [email protected]
Europe Region – +44 778 256 0738
North America Region – +1 8044 4193 44
APAC Region: +91 9356 9282 04
Visit Our Website: Towards Healthcare Research & Consulting – Expert Consulting Solutions & Research Reports
Find us on social platforms: LinkedIn | Twitter | Instagram | Medium
